Jones C - Search Results

1

PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.

Kapur S, Zipursky R, Remington G, Jones C, McKay G, Houle S. Kapur S, et al. Among authors: jones c. Am J Psychiatry. 1997 Nov;154(11):1525-9. doi: 10.1176/ajp.154.11.1525. Am J Psychiatry. 1997. PMID: 9356559

2

Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.

Tauscher-Wisniewski S, Kapur S, Tauscher J, Jones C, Daskalakis ZJ, Papatheodorou G, Epstein I, Christensen BK, Zipursky RB. Tauscher-Wisniewski S, et al. Among authors: jones c. J Clin Psychiatry. 2002 Nov;63(11):992-7. doi: 10.4088/jcp.v63n1106. J Clin Psychiatry. 2002. PMID: 12444812

3

High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study.

Kapur S, Remington G, Jones C, Wilson A, DaSilva J, Houle S, Zipursky R. Kapur S, et al. Among authors: jones c. Am J Psychiatry. 1996 Jul;153(7):948-50. doi: 10.1176/ajp.153.7.948. Am J Psychiatry. 1996. PMID: 8659621 Clinical Trial.

4

The D2 receptor occupancy profile of loxapine determined using PET.

Kapur S, Zipursky RB, Jones C, Remington GJ, Wilson AA, DaSilva J, Houle S. Kapur S, et al. Among authors: jones c. Neuropsychopharmacology. 1996 Dec;15(6):562-6. doi: 10.1016/S0893-133X(96)00100-5. Neuropsychopharmacology. 1996. PMID: 8946430

5

Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging.

Kapur S, Jones C, DaSilva J, Wilson A, Houle S. Kapur S, et al. Among authors: jones c. Nucl Med Commun. 1997 May;18(5):395-9. doi: 10.1097/00006231-199705000-00002. Nucl Med Commun. 1997. PMID: 9194079

6

The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study.

Kapur S, Zipursky R, Roy P, Jones C, Remington G, Reed K, Houle S. Kapur S, et al. Among authors: jones c. Psychopharmacology (Berl). 1997 May;131(2):148-52. doi: 10.1007/s002130050277. Psychopharmacology (Berl). 1997. PMID: 9201802

7

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J, Wilson AA, Houle S. Kapur S, et al. Among authors: jones c. Am J Psychiatry. 1998 Jul;155(7):921-8. doi: 10.1176/ajp.155.7.921. Am J Psychiatry. 1998. PMID: 9659858 Clinical Trial.

8

Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects.

Lewis R, Kapur S, Jones C, DaSilva J, Brown GM, Wilson AA, Houle S, Zipursky RB. Lewis R, et al. Among authors: jones c. Am J Psychiatry. 1999 Jan;156(1):72-8. doi: 10.1176/ajp.156.1.72. Am J Psychiatry. 1999. PMID: 9892300

9

Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy.

Kapur S, Cho R, Jones C, McKay G, Zipursky RB. Kapur S, et al. Among authors: jones c. Biol Psychiatry. 1999 May 1;45(9):1217-20. doi: 10.1016/s0006-3223(98)00204-2. Biol Psychiatry. 1999. PMID: 10331115

10

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.

Kapur S, Zipursky R, Jones C, Remington G, Houle S. Kapur S, et al. Among authors: jones c. Am J Psychiatry. 2000 Apr;157(4):514-20. doi: 10.1176/appi.ajp.157.4.514. Am J Psychiatry. 2000. PMID: 10739409 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,585 results

Search Page

Filters